Akebia Therapeutics, Inc. 4
4 · Akebia Therapeutics, Inc. · Filed Dec 2, 2016
Insider Transaction Report
Form 4
Tubridy Karen L
SVP, Chief Development Officer
Transactions
- Award
Stock Option (Right to buy)
2016-11-30+130,000→ 130,000 totalExercise: $8.61Exp: 2026-11-30→ Common Stock (130,000 underlying)
Footnotes (1)
- [F1]This option will vest as to 25% of the shares of common stock subject to the award on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter.